Please assess the completion status of the following clinical trial:

Trial Title: Dimethyl Fumarate (DMF) Observational Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Key Inclusion Criteria:~- Patients with multiple sclerosis (MS) who are newly initiating treatment with dimethyl fumarate (DMF) under routine clinical care are eligible to participate in the study.~Key Exclusion Criteria:~* Patients with previous exposure to dimethyl fumarate (DMF), Fumaderm (fumaric acid esters), or compounded fumarates.~* Patients participating in other clinical studies.~NOTE: Other protocol-defined inclusion/exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- dimethyl fumarate (DMF) (Type: None): Patients with multiple sclerosis receiving dimethyl fumarate (DMF) under routine clinical care

Based on this trial design, predict the completion outcome and termination type (if applicable).